Valiant Laboratories Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Laboratories Limited has filed a routine disclosure with the NSE under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The headline itself does not specify the underlying event, so the exact subject matter of the intimation is unclear from the available text. Regulation 30 filings are used by listed companies to inform the exchange about material events or developments. Without additional details, investors should check the full filing for the actual nature of the disclosure.
No immediate impact on shareholders can be assessed from this headline alone, as the specific event or information being disclosed is not visible. Investors should review the full filing to understand if it contains any material business update, order, contract, or other significant development.